top of page

[Explanation] Patient Case CC: Radiating Chest Pain & P2Y12 Inhibitor Selection - #MEDIGRAM

Writer's picture: Mark Nguyen, PharmD, BCEMPMark Nguyen, PharmD, BCEMP

Welcome to the #MEDIGRAM Patient Case: Chief Compliant Series. Short, concise patient cases to foster thought-provoking questions and to challenge you to ask questions! Make sure to by at the end of the week for explanations for the correct/incorrect answers.

ย 



ย 

๐Ÿ˜ฑ Patient Case CC: Radiating Chest Pain [Explanation] - #MEDIGRAM




๐Ÿ’” Which P2Y12 inhibitor should be avoided?



Clopidogrel: slow onset of action (~ 2 hours) compared to the less than 30 mins of ticagrelor and prasugrel. It is also extensively metabolized by CYP2C19.


Ticagrelor: BID frequency compared to the daily of the clopidogrel and prasugrel.


Prasugrel: Biggest concern is the contraindication in patients with a hx of stroke or TIA due to the increased risk of bleeding. Caution should also be used in elderly patients.



๐Ÿ”ฎ Website: www.pharmwyze.com




Social Links: links.pharmwyze.com






PHARMWYZE SITREP Newsletter: https://www.pharmwyze.com/sitrepnewsletter



Not medical advice. Educational purposes only. No relationships to report.



0 views0 comments

Recent Posts

See All

Yorumlar

5 รผzerinden 0 yฤฑldฤฑz
Henรผz hiรง puanlama yok

Puanlama ekleyin
bottom of page